A brutal reversal triggered by new share offering and failure to defend support lines

Reviewing Prediction vs. Actual Result

At the time of entry, we anticipated a 2.5% upside targeting the resistance level of $11.49 while monitoring for short-term support near the 20-day low support line ($9.84). However, the actual result was a -26.7% decline, resulting in a FAILED rating. At the time, an RSI (14) of 37.7 and trading volume surging to 4.37 times the 20-day average raised expectations for a rebound. Nevertheless, the core factors that failed to withstand the downward pressure were the misaligned moving averages and the dilution risk implied by the CRITICAL-rated new share/securities offering (424B5) filing. Ultimately, it is analyzed that the failure to decisively defend and hold the $9.84 support line led to a sharp drop.

What to Watch in the Next Analysis

This trade confirmed that even amidst increased trading volume and an oversold condition (RSI 37.7), support levels can be vulnerable when a bearish moving-average alignment coincides with a CRITICAL-rated public offering disclosure. In future trades, if dilution risk arising from an offering disclosure is detected, I will strictly strengthen risk management by applying more conservative stop-loss criteria or deferring entry altogether, rather than relying solely on the short-term appeal of being near a support level.